METHODIST MANSFIELD MEDICAL CENTER — History
CCN 670023 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$347M
Latest Revenue (FY2022)
+4.7%
Revenue CAGR (3yr)
18.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $317M | $339M | $347M | +2.4% | +4.7% |
| Operating Expenses | $248M | $266M | $284M | +6.9% | +7.0% |
| Operating Margin | 21.6% | 21.6% | 18.1% | -16.0% | -8.4% |
| Net Income | $68M | $73M | $63M | -14.0% | -4.0% |
| Licensed Beds | 262 | 262 | 262 | +0.0% | +0.0% |
| Total Patient Days | 65,792 | 64,382 | 62,219 | -3.4% | -2.8% |
| Medicare Day % | 25% | 20% | 20% | +2.3% | -11.0% |
| Medicaid Day % | 1% | 1% | 1% | -12.2% | -7.0% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.6% ($317M → $347M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.7%
This Hospital
+7.6%
State Avg
Latest Margin
18.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $363M | 16.4% |
| FY2024 (proj) | $378M | 14.7% |
| FY2025 (proj) | $393M | 12.9% |